Dr. Keith Wille
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Medical school
- Louisiana State University School of Medicine in New Orleans (1994)
- Years since graduation
- 32
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 107
Licensed in Alabama since 1995, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1994Medical school: Louisiana State University School of Medicine in New Orleans
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
AL license 19147 (first issued 1995; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Alabama Hospital Birmingham, AL
Medical groups
- University of Alabama Health Services Foundation, PC (2,814 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 107
- Services billed
- 472
- Patients’ average age
- 68
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 193 | 23 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 101 | 27 |
| Established patient office or other outpatient visit, 30-39 minutes | 56 | 40 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 26 | 23 |
| Aspiration of subsequent secretions of lung airway using an endoscope during same hospital stay | 25 | 14 |
| Established patient office or other outpatient visit, 40-54 minutes | 24 | 19 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | 11 |
| Hospital discharge day management, more than 30 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Birmingham, AL | 83 |
| Prednisone Other prescribers in Birmingham, AL | 52 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Birmingham, AL | 51 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Birmingham, AL | 51 |
| Gabapentin Other prescribers in Birmingham, AL | 35 |
| Doxycycline Hyclate Other prescribers in Birmingham, AL | 31 |
| Methylprednisolone Other prescribers in Birmingham, AL | 25 |
| Montelukast Sodium Other prescribers in Birmingham, AL | 23 |
| Azithromycin Other prescribers in Birmingham, AL | 20 |
| Fluticasone Propionate Other prescribers in Birmingham, AL | 18 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 18 payments worth $6,438 in total to this clinician.
| Vantive US Healthcare LLC | $5,854 |
|---|---|
| Paragonix Technologies, Inc. | $235 |
| La Jolla Pharmaceutical Company | $219 |
| Abiomed | $130 |
| Education | $4,000 |
|---|---|
| Travel and Lodging | $1,524 |
| Food and Beverage | $915 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Vantive US Healthcare LLC Jun 26, 2025 | Education Renal - Acute · Renal | $4,000 |
| Vantive US Healthcare LLC Dec 1, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Pittsburgh, PA · in-kind | $697 |
| Vantive US Healthcare LLC Apr 8, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Birmingham, IL · in-kind | $537 |
| Vantive US Healthcare LLC May 29, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Birmingham, IL · in-kind | $238 |
| Vantive US Healthcare LLC Jul 2, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Birmingham, IL · in-kind | $27.27 |
| Vantive US Healthcare LLC Jul 2, 2025 | Travel and Lodging Renal - Acute · Renal · travel to Birmingham, IL · in-kind | $24.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $50,350 in research payments for these studies, mostly to the institutions running them.
- A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Sanofi US Services Inc. · Recruiting · NCT06082037
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.